- Home
- REAL vs IMNM Comparison
REAL vs IMNM Comparison
Compare REAL & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAL
- IMNM
- Stock Information
- Founded
- REAL 2011
- IMNM 2006
- Country
- REAL United States
- IMNM United States
- Employees
- REAL N/A
- IMNM N/A
- Industry
- REAL Other Specialty Stores
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- REAL Consumer Discretionary
- IMNM Health Care
- Exchange
- REAL Nasdaq
- IMNM Nasdaq
- Market Cap
- REAL 1.2B
- IMNM 1.2B
- IPO Year
- REAL 2019
- IMNM 2020
- Fundamental
- Price
- REAL $10.26
- IMNM $15.69
- Analyst Decision
- REAL Strong Buy
- IMNM Strong Buy
- Analyst Count
- REAL 5
- IMNM 9
- Target Price
- REAL $12.20
- IMNM $24.89
- AVG Volume (30 Days)
- REAL 3.1M
- IMNM 1.8M
- Earning Date
- REAL 11-10-2025
- IMNM 11-12-2025
- Dividend Yield
- REAL N/A
- IMNM N/A
- EPS Growth
- REAL N/A
- IMNM N/A
- EPS
- REAL N/A
- IMNM N/A
- Revenue
- REAL $636,971,000.00
- IMNM $12,589,000.00
- Revenue This Year
- REAL $14.27
- IMNM N/A
- Revenue Next Year
- REAL $9.94
- IMNM $140.06
- P/E Ratio
- REAL N/A
- IMNM N/A
- Revenue Growth
- REAL 12.68
- IMNM 16.74
- 52 Week Low
- REAL $2.71
- IMNM $5.15
- 52 Week High
- REAL $11.79
- IMNM $17.08
- Technical
- Relative Strength Index (RSI)
- REAL 53.65
- IMNM 67.30
- Support Level
- REAL $9.53
- IMNM $13.53
- Resistance Level
- REAL $10.99
- IMNM $17.08
- Average True Range (ATR)
- REAL 0.60
- IMNM 1.14
- MACD
- REAL -0.13
- IMNM 0.29
- Stochastic Oscillator
- REAL 31.93
- IMNM 74.00
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.